• Explore /
  • Poster
  • / Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline <em>BRCA1 </em>and <em>BRCA2 </em>mutations (gBRCAm).

Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline BRCA1 and BRCA2 mutations (gBRCAm).

Abstract Video & Slides Poster

Authors

null

Talia Golan

The Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel

Talia Golan , Hedy L. Kindler , Philipp Schatz , Teodora Goranova , Gershon Y. Locker , Karen Cui , Katia Schlienger , David McGuinness , J. Andrew Williams , Maria Orr , Thorsten Gutjahr , Yu-Zhen Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Pancreatic Cancer

Track

Pancreatic Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

NCT02184195

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 420)

DOI

10.1200/JCO.2021.39.3_suppl.420

Abstract #

420

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Talia Golan

First Author: Hyun Kyoo Yoo

First Author: Kim Anna Reiss

First Author: Vincent Chung